ALKERMES PHARMA IRELAND LIMITE

Canadian Trademark Information

Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, clinical depression, major depressive disorder, bipolar disorder, anxiety and panic disorders, substance abuse and dependence, depressive disorders, psychosis, irritability associated with autistic disorder, and reward disorders, namely eating disorders; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of neurodegenerative diseases, namely Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis (ALS); Pharmaceutical compounds; namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of cardiovascular diseases; Pharmaceutical compounds; namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of metabolic diseases, namely, diabetes, dyslipidemia and obesity. Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for th...

Perfect for these industries

Words that describe this mark

pharmaceutical   compounds       prodrugs   chemical   derivatives   pharmaceutically   active   ingredients   treatment   central   nervous   diseases   disorders     psychiatric   disorders     schizophrenia     clinical   depression     major   depressive   disorder     bipolar   disorder     anxiety   panic   disorders     substance   abuse  
On Thursday, February 19, 2015, a canadian trademark registration was filed for the above pictured logo by ALKERMES PHARMA IRELAND LIMITE CONNAUGHT HOUSE 1 BURLINGTON ROAD, DUBLIN 4, IRELAND . The Canadian IP office has given the trademark application number of 1715911. The current status of this trademark filing is Application published. The correspondent listed for is GOWLING WLG (CANADA) LLP of SUITE 1600, 1 FIRST CANADIAN PLACE, 100 KING STREET WEST, ONTARIO, CANADA M5X1G5 The trademark is filed in the description of Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, clinical depression, major depressive disorder, bipolar disorder, anxiety and panic disorders, substance abuse and dependence, depressive disorders, psychosis, irritability associated with autistic disorder, and reward disorders, namely eating disorders; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of neurodegenerative diseases, namely Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis (ALS); Pharmaceutical compounds; namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of cardiovascular diseases; Pharmaceutical compounds; namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of metabolic diseases, namely, diabetes, dyslipidemia and obesity. , Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, clinical depression, major depressive disorder, bipolar disorder, anxiety and panic disorders, substance abuse and dependence, depressive disorders, psychosis, irritability associated with autistic disorder, and reward disorders, namely eating disorders. .
Word Mark: Logo Mark
Current Status:
Application published
LIVE Mark!
3/10/2017
Application Number: 1715911
Filing Date: Thursday, February 19, 2015
Filing Place: Canada
Registration Date: Not Available
Register Type: Primary
Type Of Mark: Trademark
Mark Feature: Figurative
Use In Commerce: No
Publication Registration: Wednesday, November 23, 2016
Opposition: 11/23/2016 - 11/23/2016
Last Applicant/Owner: CONNAUGHT HOUSE 1 BURLINGTON ROAD
DUBLIN 4
IRELAND
Correspondent:
SUITE 1600
1 FIRST CANADIAN PLACE
100 KING STREET WEST
ONTARIO
CANADA M5X1G5
Logo Design Information
Design Feature:
(1) Vortices, rotary movements, tornadoes -- Note: Not including astronomic orbits (1.13.1), atomic orbits (1.13.1), concentric circles (26.1.4 or 26.1.5) and spirals (26.1.5).
(2) Surfaces or backgrounds covered with repeated geometrical figures or designs
(3) Surfaces or backgrounds covered with other repeated geometrical figures or designs
(4) Triangles with dark surfaces or parts of surfaces
(5) Several triangles, juxtaposed, joined or intersecting
(6) Triangular figures with one or more convex or concave sides
(7) Red, pink, orange
(8) Green
(9) Blue
(10) White, grey, silver
Goods and Services Information
Description:
(1) - Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, clinical depression, major depressive disorder, bipolar disorder, anxiety and panic disorders, substance abuse and dependence, depressive disorders, psychosis, irritability associated with autistic disorder, and reward disorders, namely eating disorders; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of neurodegenerative diseases, namely Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis (ALS); Pharmaceutical compounds; namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of cardiovascular diseases; Pharmaceutical compounds; namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of metabolic diseases, namely, diabetes, dyslipidemia and obesity.
(2) - Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, clinical depression, major depressive disorder, bipolar disorder, anxiety and panic disorders, substance abuse and dependence, depressive disorders, psychosis, irritability associated with autistic disorder, and reward disorders, namely eating disorders.

Classification Information

Class Code: 005 - Pharmaceutical Products
Description: Pharmaceuticals and herbicides

Matter History Events

Status Date: Record Status Description
2018-01-18 National prosecution history entry - extension of time
2017-03-10 National prosecution history entry - allowance notice sent
2017-03-10 National prosecution history entry - allowed
2016-11-23 Application published - advertised
2016-11-18 National prosecution history entry - Extracted for Advertisement
2016-11-03 Application accepted - approved
2016-09-13 National prosecution history entry - approval notice sent
2016-04-21 National prosecution history entry - extension of time
2016-02-25 National prosecution history entry - Agent Name Changed
2016-02-25 National prosecution history entry - Rep for Service Name Changed
2015-10-02 Filing date accorded - Search Recorded
2015-10-02 National prosecution history entry - Examiner's First Report
2015-02-23 Filing date accorded - formalized
2015-02-19 Application filed - filed
2015-02-19 National prosecution history entry - created
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. LegalForce - #1 Trademark Filing since 2010.
  • 2. Describe how your business or product is being used. Register your mark in 180+ countries.
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

testimonial

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!